智通財經APP獲悉，香港聯交所最新資料顯示，7月15日，Barclays PLC增持昭衍新藥(06127)327.982萬股，每股作價24.2508港元，總金額約為7953.83萬港元。增持後最新持股數目約為728.53萬股，最新持股比例為6.12%。

補充資料：Notifiable interest first occurred due to increase in Equity shares. BBPLCs interests in 2068664 shares long and short and BCSLs interests in 1295444 shares long and 773220 shares short as disclosed at box 22 pertain to an intragroup hedge between BBPLC and BCSL. Interests arising under the hedge are not double counted at BPLCs level.